Harnessing extracellular vesicles for ischemic stroke management
Regenerative Biomaterials · 22.01.2026 · 13
DOI: 10.1093/rb/rbag038 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Regenerative Biomaterials, online erschienen am 05.03.2026. Verfasst von Khan Haroon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 229 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Innovation Committee, Guangdong Basic and Applied Basic Research Foundation, National Natural Science Foundation of China.
Themen: Schlaganfall
Abstract (Originalsprache)
Extracellular vesicles (EVs) are versatile, cell-derived complexes that serve as a complete package of biologically important molecules, released during both normal and pathological processes. With rapid advancements in EVs research, there has been a shift in its therapeutic applications, clinical development and commercialization. EVs have been extensively studied for their potential to mitigate ischemic stroke pathological mechanisms, such as excitotoxicity, immune response, blood–brain barrier (BBB) dysfunction, neuroinflammation and apoptosis. EVs’ innate ability to protect molecular cargo (proteins, DNA or RNA) from enzymatic degradation, their natural ability to traverse BBB, high cargo-loading efficiency and superior biocompatibility make them ideal candidates for targeted drug delivery systems in ischemic stroke. Their presence in most biofluids and changes in their contents during disease conditions, support investigation of EVs as promising minimally invasive biomarkers for the early diagnosis and treatment monitoring of ischemic stroke. Moreover, EVs in combination with other therapeutic agents have considerable potential for clinical translation. This perspective provides a comprehensive overview of current literature on EV-based systems in stroke management, highlighting their role as standalone therapeutics, presenting opportunities for cargo delivery, biomarkers discovery and synergistic component of combination therapies. Additionally, the ongoing clinical trials are discussed along with the challenges and considerations required to advance the clinical translation and adaptation of EV-based systems for ischemic stroke management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, The Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People's Hospital of Shenzhen, Shenzhen, Guangdong 518172, China.
- Department of Pharmaceutical Science, Division of Biomedical Health Sciences, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong 518172, China.
- Department of Biomedical Sciences, Division of Biomedical Health Sciences, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong 518172, China.
- NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing 210009, Chi…
- Division of Cardiovascular Surgery, Toronto General Hospital Research Institute, University Health Network, Toronto, ON M5G 1L7, Canada.
- Division of Cardiac Surgery, Department of Surgery, University of Toronto, Toronto, ON M5B 1L7, Canada.
ORCID-Profile: Zhaoting Li
Förderung
- Shenzhen Science and Technology Innovation Committee
- Guangdong Basic and Applied Basic Research Foundation
- National Natural Science Foundation of China
- University Development Research Start-up Fund
- Pengcheng Peacock Project Special Fund
Zitieren
APA
Haroon, K., Yu, J., Li, R., Ren, C., & Li, Z. (2026). Harnessing extracellular vesicles for ischemic stroke management. Regenerative Biomaterials, 13. https://doi.org/10.1093/rb/rbag038
Vancouver
Haroon K, Yu J, Li R, Ren C, Li Z. Harnessing extracellular vesicles for ischemic stroke management. Regenerative Biomaterials. 2026;13. doi:10.1093/rb/rbag038
BibTeX
@article{Haroon2026,
author = {Haroon, Khan and Yu, Jie and Li, Renke and Ren, Chuancheng and Li, Zhaoting},
title = {Harnessing extracellular vesicles for ischemic stroke management},
journal = {Regenerative Biomaterials},
year = {2026},
volume = {13},
doi = {10.1093/rb/rbag038}
}
EUVIMED